Multiple myeloma

Showing 9 of 0 results

• Inequities in autologous stem cell transplantation, chimeric antigen receptor T-cell therapy and clinical trial participation in patients receiving second-line and later multiple myeloma treatment

  2023 ASH Annual Meeting and Exposition

  • Publication summary
  • Publications
  • Health equity
  • Multiple myeloma
• Performance of newer staging systems for myeloma in a contemporary, large cohort of patients in the United States

  2023 ASH Annual Meeting and Exposition

  • Publication summary
  • Publications
  • Multiple myeloma
• Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

  Blood Cancer Journal

  • Publication summary
  • Publications
  • Treatment patterns
  • Multiple myeloma
• A systematic approach towards missing lab data in electronic health records: A case study in non-small cell lung cancer and multiple myeloma

  CPT: Pharmacometrics & Systems Pharmacology

  • Publication summary
  • Publications
  • Quality improvement
  • Methodology
  • Multiple myeloma
  • Non-small cell lung cancer
• RWD-derived response in multiple myeloma

  PLOS ONE

  • Publication summary
  • Publications
  • Methodology
  • Multiple myeloma
• The COVID-19 pandemic and in-person visit rate disruptions among patients with hematologic neoplasms in the US in 2020 to 2021

  JAMA Network Open

  • Publication summary
  • Publications
  • Treatment patterns
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
  • Chronic lymphocytic leukemia
• Racialized economic segregation and inequities in survival among patients with multiple myeloma

  Value in Health

  • Publication summary
  • Publications
  • Health equity
  • Multiple myeloma
• Do the characteristics of the site of care influence outcomes? Associations between community practice-level characteristics and real-world overall survival among patients with multiple myeloma

  Value in Health

  • Publication summary
  • Publications
  • Health equity
  • Methodology
  • Multiple myeloma
• Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy

  Blood Cancer

  • Real-world evidence
  • Publication summary
  • Publications
  • Drug discovery
  • Multiple myeloma